Who is the owner of Injective protocol?

Could you possibly clarify for me who exactly holds the reins of the Injective protocol? I've been trying to dig into its background, but the ownership structure seems to be a bit of a mystery. Is it a single individual, a group of developers, or perhaps an organization? I'm also curious about the governance structure of this protocol. How are decisions made? Are there any key figures or stakeholders that have significant influence? Your insights would be greatly appreciated.